What to Recheck When CVS Caremark Wegovy Coverage Changes During the Year

Three separate things can change and each looks identical at the pharmacy counter: the formulary template, the employer’s decision about whether to cover weight-management drugs, and the member’s own authorization. Check them in that order. Two of the three are outside anyone’s control, and the third, an expired authorization, is the one most often responsible and the easiest to fix.

Why a card that worked in March fails in September

A pharmacy benefit has layers, and they move on different schedules. A benefit manager revises formulary templates on a published cycle, at least annually and sometimes quarterly. A plan sponsor decides separately what to buy, and can drop or add the weight-management category at renewal. On top of both, the individual member holds an authorization with an expiry date attached to it.

Because all three failures produce the same rejection at the register, people reach for the wrong explanation. Assuming the formulary changed when in fact an approval lapsed wastes days on calls that a prescriber’s office could have resolved in one afternoon.

Start with the authorization, because it is the likeliest cause

Authorizations are written for a fixed period, commonly six or twelve months. Continuation is a fresh review, not an automatic rollover, and reauthorization frequently requires documented response to treatment. Nothing notifies the patient. The expiry surfaces as a refill that will not process.

The fix is procedural: the prescribing office files a continuation request with current weight data and any required follow-up information. Setting a reminder sixty days before the end date turns a coverage emergency into a routine piece of paperwork.

Then check whether the plan year turned over

Plan years do not always match calendar years. An employer with a July renewal changes formulary, tiering, and cost sharing in the middle of what everyone else calls the year. Two things commonly change at that moment. The deductible resets, which alters what a member pays without altering whether the drug is covered. And the sponsor may have switched benefit managers entirely, which invalidates authorizations issued by the previous administrator.

A benefit manager change is worth identifying quickly, because prior approvals rarely transfer intact. Some plans honor existing authorizations for a transition period; others require everything to be resubmitted. Asking which applies is a single question to the benefits administrator.

Then look at the formulary itself

Formulary changes come in several flavors, and only some of them are disruptive. A tier move raises or lowers cost sharing. A new utilization rule adds a review step. A removal takes the product off the covered list entirely, usually in favor of a therapeutic alternative that carries a better net price after rebates. Research tracking benefit manager exclusion lists has documented how quickly these lists grow and how many people a single removal can affect.

Plans generally give advance notice of negative changes and often provide a transition or continuity supply for members already stabilized on a product. That notice arrives by mail or through the plan portal, which is a good argument for reading benefit correspondence rather than filing it unopened.

What changed	How it shows up	First move
Authorization expired	Refill rejects, nothing else changed	Prescriber files continuation
Deductible reset	Covered, but the price jumped	Recalculate the year, not the month
Tier moved	Same drug, higher coinsurance	Ask whether an exception lowers the tier
Product removed	Rejects as non-formulary	Exception request or preferred alternative
Category dropped by employer	All weight-management drugs reject	Price self-pay routes, raise it at renewal
New benefit manager	Approvals no longer recognized	Confirm transition rules, resubmit

The change that is not a coverage change

Copay accumulator and maximizer arrangements deserve separate attention because they confuse people badly. Under these designs, manufacturer assistance paid on a member’s behalf may not count toward the deductible or out-of-pocket maximum. Coverage status never changes. What changes is when the member starts paying in full, which can arrive abruptly and feel exactly like a denial.

If the category really is gone

When an employer drops weight-management coverage mid-cycle, appeals do not help, because no clinical rule was applied. The realistic options are the manufacturer’s self-pay channel, which keeps the patient on the approved product, or a compounded GLP-1 provider, and both deserve pricing across a full year rather than a first month. Compounded semaglutide is not an FDA-approved product, and the agency has been direct that compounded medicines are not evaluated for safety, effectiveness, or quality before they reach patients.

Stopping is the option nobody prices properly. In the STEP-1 trial extension, participants regained roughly two-thirds of the weight lost within a year of withdrawal, which makes an interrupted course an expensive way to arrive back where the treatment started. Health economics work on the relative value of anti-obesity medication is worth reading before treating a coverage gap as a natural stopping point.

Because an interrupted course is costly, pricing the alternatives properly is worth the hour it takes. Direct-pay providers make that comparison easier when they post figures openly, and reading a few of them, among them Ro, Hims and Hers, and HealthRX, which lists cash pricing for branded Wegovy as well as compounded semaglutide, shows where the real twelve-month cost lands.

Questions people ask

Is a plan allowed to remove a drug in the middle of the year?

Generally yes, subject to notice requirements that vary by plan type and by state. Medicare drug plans operate under specific rules about mid-year changes and member notification. Commercial plans have more latitude, and self-funded employer plans set much of their own timetable within federal requirements.

Does an existing approval survive a formulary change?

Sometimes. Plans often honor authorizations already in force until the stated end date, and many offer a transition supply for members stabilized on a removed product. That protection is not universal and usually does not survive a change of benefit manager. Confirm it in writing rather than assuming.

Why did the price change without any letter arriving?

Deductible resets and accumulator designs both do this. Neither is a coverage decision, so neither triggers a coverage notice. Checking the claim history in the plan portal shows whether the plan still paid its share, which distinguishes a cost-sharing shift from an actual loss of coverage.

Can an employer be persuaded to add the category back?

Occasionally, and it works on an annual cycle rather than on demand. Benefits committees respond to aggregated employee interest and to cost modeling, and published analyses of coverage expansion give both sides of that argument. One member asking mid-year moves nothing; a documented request ahead of renewal sometimes does.